Ligand validation:4YR0

DCP: 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE

DCP is a Ligand Of Interest in 4YR0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4YR0_DCP_A_501	98%	55%	0.067	0.986	0.83	0.91	1	2	2	0	100%	1
4YQW_DCP_A_501	96%	54%	0.074	0.986	0.71	1.04	-	2	2	0	100%	1
8V7A_DCP_A_504	94%	71%	0.083	0.981	0.64	0.49	-	-	2	0	100%	1
4YR3_DCP_A_501	93%	52%	0.086	0.981	0.86	0.99	1	1	2	0	100%	1
4YP3_DCP_A_501	92%	54%	0.091	0.982	0.95	0.85	1	1	2	0	100%	1
4EEY_DCP_A_501	92%	54%	0.099	0.989	0.79	0.97	-	1	0	0	100%	1
3IAY_DCP_A_986	99%	51%	0.058	0.986	0.9	0.98	1	2	2	0	100%	1
2HVW_DCP_C_1203	97%	53%	0.062	0.977	0.86	0.95	1	1	0	0	100%	1
4RZR_DCP_D_401	97%	47%	0.069	0.984	0.84	1.19	-	3	0	0	100%	1
7RBH_DCP_A_402	97%	57%	0.069	0.983	0.83	0.81	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.